• Keine Ergebnisse gefunden

5. MATERIAL  AND  METHODS

5.1. Chemicals  and  Buffers

  UbcX  dissociates  XErp1  from  the  APC/C                                                                                                        Material  and  Methods  

 

55  

5. MATERIAL  AND  METHODS  

5.1. Chemicals  and  Buffers  

All  materials  and  reagents  were  obtained  from  commercial  suppliers  and  used   without  further  purification,  unless  specified.  Chemicals  were  at  least  of  purity   grade   p.a.   (pro   analysi).   Buffers   and   solutions   were   prepared   with   deionized   water  from  a  Milli-­‐Q  system  (Millipore)  and  either  autoclaved  or  sterile  filtered   before  use.  Standard  buffers  utilized  in  this  study  are  reported  below.  

Phosphate   Buffered   Saline   (PBS):   137   mM   NaCl2,   2.7   mM   KCl2,   10.2   mM   Na2HPO4,  1.8  mM  KH2PO4,  pH  7.4  

Tris  Buffered  Saline  (TBS):  10  mM  Tris-­‐HCl  pH  7.6,  150  mM  NaCl2  

3x  laemmli  buffer  (3xlb):  180  mM  Tris  HCl  pH  6.8,  30%  (w/v)  Glycerole  ,10  %   (w/v)  SDS

5.2. Plasmids  

5.2.1. Plasmids  generated  in  this  study  

The  plasmids  that  have  been  used  in  this  for  protein  expression  or  coupled  in   vitro  transcription/translation  are  listed  below  referring  to  the  TUM  number  in   the  Mayer  laboratory  plasmid  collection:  

Table  5.1.:  Plasmids    

Name   Insert   Specification   Vector   Tag   Reference  

TUM606   hu_securin   wt,fl   pCS2-­‐F/A   -­‐   N.  Rauh  

TUM1144   hu_UbcH10   wt,fl   pQE80-­‐F/A   6xhis   E.  Hörmanseder  

TUM1145   hu_UbcH10   C114S,  fl   pQE80-­‐F/A   6xhis   E.  Hörmanseder  

TUM1165   Xe_Usp44   wt,  fl   pQE80-­‐F/A   6xhis   E.  Hörmanseder  

TUM1166   Xe_Usp44   C283A,  fl   pQE80-­‐F/A   6xhis   E.  Hörmanseder  

TUM1245   Xe_UbcX   wt,fl   pQE80-­‐F/A   6xhis   E.  Hörmanseder  

 

    UbcX  dissociates  XErp1  from  the  APC/C                                                                                                        Material  and  Methods  

 

57   5.2.3. Cloning  and  Mutagenesis  

Full-­‐length   H.s.   UbcH10,   X.l.   UbcX,   X.l.   USP44   and   X.l.   Cdc20   were   amplified   from  cDNA  libraries  using  primers  described  (Table  5.2.)  and  subcloned  into  a   the  corresponding  vectors  (Table  5.1.).  Standard  molecular  biology  techniques   have  been  used  to  generate,  clone  and  subclone  DNA  encoding  the  genes  of   interest.   Plasmid   DNA   was   u   purified   from   the   E.   coli   strain   TG1   using   the   Qiagen   Mini   kit   according   to   the   manufacturers   instructions.   DNA   fragments   were   isolated   from   agarose   gels   using   the   Qiagen   gel   elution   kit.   Restriction   digests   were   carried   out   as   recommended   by   the   enzyme   supplier   (New   England   Biolabs).   Polymerase   chain   reaction   (PCR)   was   carried   out   using   Pfu   Turbo  polymerase  (Stratagene).  Ligation  reactions  were  done  overnight  at  18  

°C   with   T4   ligase   (Roche).   Catalytically   inactive   UbcH10ci   and   UbcXci   were   generated   by   mutating   cystein   114   of   UbcH10wt   and   cystein   114   of   UbcXwt   respectively,  to  serine  using  the  QuikChange  kit  (Stratagene)  according  to  the   manufacturer’s  protocol.  

5.3. Proteins  

5.3.1. His-­‐  tagged  protein  expression  in  bacteria  

Bacteria   of   the   E.   coli   strain   JM109RIL   were   transformed   with   a   plasmid   encoding  for  the  6xhis  -­‐tagged  Ubiquitinwt  ,  UbiquitinΔGG,  UbcH10wt,  UbcH10ci,   UbcXwt  and  UbcXci  and  an  overnight  culture  was  grown  in  100  ml  1x  LB  (Roth)   containing  100µg/ml  ampicillin,  34µg/ml  chloramphenicol  and  expanded  to  a   2L   culture.   When   the   culture   reached   an   OD600=0,6,   protein   expression   was   induced  by  adding  IPTG  to  a  final  concentration  of  1  mM.  The  induction  period   was  4  hours  at  37°C,  after  which  the  bacteria  were  harvested  by  centrifugation   at  6000xg  for  10  minutes  at  4°C  and  the  bacterial  pellets  were  snap  frozen  in   liquid  nitrogen  and  stored  at  -­‐80°C.    

    UbcX  dissociates  XErp1  from  the  APC/C                                                                                                        Material  and  Methods  

  5.3.2. His-­‐tagged  protein  expression  in  SF9  cells  

SF9   insect   cells   were   cultured   at   27   °C   in   TC-­‐100   medium   (Gibco   or   PAN)   supplemented  with  10  %  fetal  calf  serum  (FCS)  and  antibiotics    (1000  units/ml   penicillin  G  and  1  mg/ml  streptomycin).  For  protein  expression,  SF9  cells  were   seeded  on  15  cm  culture  dishes  at  a  density  of  2x107  cells  per  dish  and  infected   with   the   Cdc20   encoding   baculovirus,   which   was   generated   according   to   the   Bac-­‐to-­‐Bac   protocol   provided   by   Invitrogen.   After   48h   the   cells   were   resuspended  in  culture  medium  and  collected  by  centrifugation  at  400xg  for  10   min.  The  cell-­‐pellet  was  snap  frozen  in  liquid  nitrogen  and  stored  at  -­‐80°C.    

5.3.3. His-­‐tagged  protein  purification  from  bacteria  and  SF9  cells  

Cell   pellets   were   thawed   at   room   temperature   in   10   ml   IMAC5   lysis   buffer   [5mM   Imidazol,   300mM   NaCl,   0.1%Triton   X-­‐100,   1x   complete   protease   inhibitors  (Roche),  20mM  Tris-­‐HCl  pH  8.0]  per  liter  of  original  bacterial  culture   or  500  ml  of  SF9  cell  suspension,  respectively.  Cells  were  lysed  with  an  Emulsi-­‐

Flex-­‐C5  and  the  lysate  was  cleared  by  centrifugation  at  40.000  g  for  15  minutes   at  4.°C.  His-­‐tagged  proteins  were  isolated  by  incubating  the  cleared  lysate  with   0,25  ml  of  NTA-­‐  or  NDA-­‐agarose  (Quiagen  or  Macherey-­‐Nagel,  respectively)  per   liter  of  original  culture  for  4  h  at  4°C.  The  resin  was  washed  two  times  in  batch   with   20   ml   IMAC20(TA)   [20mM   Imidazol,   300mM   NaCl,   1mM   NaATP,   1mM   MgCl2,  0.1%Triton  X-­‐100,  1x  complete  protease  inhibitors  (Roche),  20mM  Tris-­‐

HCl  pH  8.0]  and  once  with  20  ml  of  IMAC20  without  ATP  for  15  min  at  4°C;  the   beads  were  collected  by  centrifugation  at  1000xg  for  5min  at  4°C.  The  beads   were  transferred  into  a  column  (15  ml,  Biorad).  Proteins  were  eluated  with  one   fraction   of   0,25   ml   and   five   fractions   of   0,5   ml   IMAC200   [200mM   Imidazol,   300mM   NaCl,   0.1%Triton   X-­‐100,   1x   complete   protease   inhibitors   (Roche),   20mM   Tris-­‐HCl   pH   8.0].   The   protein-­‐containing   fractions   were   dialyzed   overnight  at  4°C  into  an  appropriate  storage  buffer  [150  mM  KCl,  1mM  DTT,   10%   Glycerol,   20   mM   K-­‐HEPES   pH7.7].   Finally,   protein   aliquots   were   snap  

    UbcX  dissociates  XErp1  from  the  APC/C                                                                                                        Material  and  Methods  

 

59   frozen  in  liquid  nitrogen  and  stored  at  -­‐80°C.  When  the  protein-­‐solutions  were   thawed   again,   the   samples   were   centrifuged   for   10   min   at   186.000xg   to   remove   potential   protein   precipitates   and   the   protein   concentration   was   measured  by  standard  Bradford  assays.    

5.3.4. Coupled  in  vitro  transcription/translation  (IVT)  

IVT  reactions  to  make  35S-­‐labelled  proteins  were  carried  out  using  the  TNT  kit     (Promega)  in  wheat-­‐germ  extract  according  to  the  manufacturer’s  instructions,   except  1  µg  of  plasmid  DNA  encoding  the  protein  of  interest  and  S35-­‐labelled   methionine  was  used  and  the  reaction  was  incubated  at  30°C  for  2  hours.  The   successful   translation   of   the   protein   was   analyzed   by   SDS-­‐PAGE   and   autoradiographic  analysis.  

5.4. Antibodies  

5.4.1. Antibodies  used  in  this  study:    

Antibodies  against  Cdc20  and  cyclin  B2  were  purchased  from  Abcam,  against   Cdc27  and  α-­‐tubulin  from  Sigma.  Antibodies  against  βTRCP  were  a  kind  gift  of   T.   Lorca.   Anti-­‐XErp1   antibodies   were   described   previously   (Schmidt   et   al,   2005).   Anti-­‐UbcX   antibodies   were   generated   by   immunizing   rabbits   with   full-­‐

length  6xhis-­‐UbcX  and  affinity  purification  of  the  anti-­‐UbcX  antibodies  from  the   obtained   serum.   Anti-­‐USP44   antibodies   were   generated   by   immunizing   two   rabbits  with  a  mix  of  USP44-­‐232  peptide  (KMNQKNSPTTKQKTPAPTSDKAC)  and   USP44-­‐CT   peptide   (C-­‐ENGHLSDTLPVHGSPQSPPR).   Antibodies   were   affinity   purified  using  6xhis-­‐USP441-­‐200,  USP44-­‐232  peptide  or  USP44-­‐CT  peptide.    

5.4.2. Affinity  purification  of  antibodies  

SulfoLink  coupling  resin  (Pierce)  was  equilibrated  at  room  temperature  and  1,5   ml  resin  was  transferred  into  a  15  ml  plastic  column  (Biorad).  The  column  was  

    UbcX  dissociates  XErp1  from  the  APC/C                                                                                                        Material  and  Methods  

  washed  with  10  ml  of  coupling  buffer  [5mM  EDTA-­‐Na,  50mM  Tris  pH8]  and  1.5-­‐

2   mg   antigen   with   a   concentration   of   1mg/ml   was   applied.   The   resin   was   incubated  with  the  antigen  for  30  min  at  room  temperature  by  end-­‐over-­‐end   mixing.   The   column   was   put   upright   for   30min   at   room   temperature.   The   antigen-­‐coupled   resin   was   washed   with   6   ml   coupling   buffer.   Nonspecific   binding   sites   on   the   resin   were   blocked   by   the   addition   of   4   ml   quenching   buffer  [50mM  L-­‐cystein,  50mM  Tris,  5mM  EDTA-­‐Na,  pH8]  to  the  column.  After   45  min  incubation  at  room  temperature,  the  column  was  washed  with  at  least   6x   10   ml   of   wash   solution   [1M   NaCl,   50mM   Tris,   5mM   EDTA-­‐Na,   pH8].   After   this   procedure,   the   ligand   is   covalently   coupled   to   the   resin   and   the   column   can  be  used  for  affinity  purifications.  If  needed,  the  column  was  stored  at  4°C   in  storage  buffer  [1x  PBS,  0,05%  NaN3].    

For  antibody  affinity-­‐purification,  the  column  was  washed  with  10  ml  1x  TBS,   10  ml  elution  buffer  [150  mM  NaCl,  200mM  glycine  pH  2.3]  and  TBS  until  the   flow  through  has  a  pH=7,5.  The  serum  (2  ml  of  anti-­‐UbcX  serum,  5  ml  for  anti-­‐

USP44  serum)  was  filtered  shortly  before  it  was  applied  to  the  column  through   a  0,45mm  filter.  1x  TBS  was  added  to  the  serum  to  reach  a  final  volume  of  10   ml   and   the   solution   was   incubated   with   the   column   over   night   at   4°C.   The   column  was  washed  with  3x  10  ml  washing  buffer  [500mM  NaCl,  0.2%  Triton   X100,  20mM  Tris  pH  7.5]  and  with  3x  10  ml  TBS.  The  antibodies  were  eluted   with  10x  500  ml  elution  buffer  into  tubes  provided  with  50-­‐100  ml  (determine   volume  empirically)  Tris  pH  8.5  to  reach  pH  7.5  after  elution.  The  column  was   washed   with   6x10   ml   TBS   and   store   in   column   storage   buffer.   The   antibody   eluates   were   dialyzed   against   1xPBS   containing   10%   Glycerol,   aliquoted   and   snap-­‐frozen  at  -­‐80°C.